Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19

Published:April 10, 2020DOI:https://doi.org/10.1016/j.jinf.2020.04.002

      Abstract

      Background

      Several studies have described the clinical characteristics of patients with novel coronavirus (SARS-CoV-2) infected pneumonia (COVID-19), indicating severe patients tended to have higher neutrophil to lymphocyte ratio (NLR). Whether baseline NLR could be an independent predictor of in-hospital death in Chinese COVID-19 patients remains to be investigated.

      Methods

      A cohort of patients with COVID-19 admitted to the Zhongnan Hospital of Wuhan University from January 1 to February 29 was retrospectively analyzed. The baseline data of laboratory examinations, including NLR, were collected. Univariate and multivariate logistic regression models were developed to assess the independent relationship between the baseline NLR and in-hospital all-cause death. A sensitivity analysis was performed by converting NLR from a continuous variable to a categorical variable according to tertile. Interaction and stratified analyses were conducted as well.

      Results

      245 COVID-19 patients were included in the final analyses, and the in-hospital mortality was 13.47%. Multivariate analysis demonstrated that there was 8% higher risk of in-hospital mortality for each unit increase in NLR (Odds ratio [OR] = 1.08; 95% confidence interval [95% CI], 1.01 to 1.14; P = 0.0147). Compared with patients in the lowest tertile, the NLR of patients in the highest tertile had a 15.04-fold higher risk of death (OR = 16.04; 95% CI, 1.14 to 224.95; P = 0.0395) after adjustment for potential confounders. Notably, the fully adjusted OR for mortality was 1.10 in males for each unit increase of NLR (OR = 1.10; 95% CI, 1.02 to 1.19; P = 0.016).

      Conclusions

      NLR is an independent risk factor of the in-hospital mortality for COVID-19 patients especially for male. Assessment of NLR may help identify high risk individuals with COVID-19.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Faria S.S.
        • Fernandes P.J.
        • Silva M.J.
        The neutrophil-to-lymphocyte ratio: a narrative review.
        Ecancermedicalscience. 2016; 10: 702
        • Azab B.
        • Zaher M.
        • Weiserbs K.F.
        Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction.
        Am J Cardiol. 2010; 106: 470-476
        • Guthrie G.J.
        • Charles K.A.
        • Roxburgh C.S.
        • Horgan P.G.
        • McMillan D.C.
        • Clarke S.J.
        The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer.
        Crit Rev Oncol Hematol. 2013; 88: 218-230
        • Giede-Jeppe A.
        • Bobinger T.
        • Gerner S.T.
        Neutrophil-to-Lymphocyte Ratio Is an Independent Predictor for In-Hospital Mortality in Spontaneous Intracerebral Hemorrhage.
        Cerebrovasc Dis. 2017; 44: 26-34
        • Ha Y.J.
        • Hur J.
        • Go D.J.
        Baseline peripheral blood neutrophil-to-lymphocyte ratio could predict survival in patients with adult polymyositis and dermatomyositis: A retrospective observational study.
        Plos One. 2018; 13e190411
        • Qin C.
        • Zhou L.
        • Hu Z.
        Dysregulation of immune response in patients with COVID-19 in Wuhan, China.
        Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2020;
        • Wang D.
        • Hu B.
        • Hu C.
        Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
        JAMA. 2020;
        • Yang X.
        • Yu Y.
        • Xu J.
        Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
        Lancet Respir Med. 2020;
        • Chan J.F.
        • Yuan S.
        • Kok K.H.
        A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.
        Lancet. 2020; 395: 514-523
      1. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. January 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severeacute-respiratoryinfection-when-novelcoronavirus-(ncov)-infection-is-suspected. (accessed March 29, 2020). 2020.

        • Corman V.M.
        • Landt O.
        • Kaiser M.
        Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.
        Euro Surveill. 2020; 25
      2. World Health Organization. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance. https://www.whoint/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117 (accessed March 29, 2020). 2020.

        • Zhou F.
        • Yu T.
        • Du R.
        Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
        Lancet. 2020;
        • Mo P.
        • Xing Y.
        • Xiao Y.
        Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China.
        Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2020;
        • Ye G.
        • Pan Z.
        • Pan Y.
        Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation.
        The Journal of infection. 2020;
        • Channappanavar R.
        • Perlman S.
        Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.
        Semin Immunopathol. 2017; 39: 529-539
        • Min C.K.
        • Cheon S.
        • Ha N.Y.
        Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity.
        Sci Rep. 2016; 6: 25359
        • Alfaraj S.H.
        • Al-Tawfiq J.A.
        • Assiri A.Y.
        • Alzahrani N.A.
        • Alanazi A.A.
        • Memish Z.A.
        Clinical predictors of mortality of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: A cohort study.
        Travel Med Infect Dis. 2019; 29: 48-50
        • Leist S.R.
        • Jensen K.L.
        • Baric R.S.
        • Sheahan T.P.
        Increasing the translation of mouse models of MERS coronavirus pathogenesis through kinetic hematological analysis.
        Plos One. 2019; 14e220126
        • Huang C.
        • Wang Y.
        • Li X.
        Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
        Lancet. 2020; 395: 497-506